These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21245992)

  • 1. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
    Andersen V; Christensen J; Ernst A; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
    World J Gastroenterol; 2011 Jan; 17(2):197-206. PubMed ID: 21245992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes.
    Andersen V; Christensen J; Overvad K; Tjønneland A; Vogel U
    BMC Cancer; 2010 Sep; 10():484. PubMed ID: 20836841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
    Glas J; Seiderer J; Fischer D; Tengler B; Pfennig S; Wetzke M; Beigel F; Olszak T; Weidinger M; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Diegelmann J; Czamara D; Brand S
    Inflamm Bowel Dis; 2011 Sep; 17(9):1917-24. PubMed ID: 21830270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
    Dring MM; Goulding CA; Trimble VI; Keegan D; Ryan AW; Brophy KM; Smyth CM; Keeling PW; O'Donoghue D; O'Sullivan M; O'Morain C; Mahmud N; Wikström AC; Kelleher D; McManus R
    Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnane X Receptor Polymorphisms and Risk of Inflammatory Bowel Disease: A Meta-Analysis.
    Guo X; Yan M
    Immunol Invest; 2017 Aug; 46(6):566-576. PubMed ID: 28742404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the PXR gene locus in inflammatory bowel diseases.
    Martínez A; Márquez A; Mendoza J; Taxonera C; Fernández-Arquero M; Díaz-Rubio M; de la Concha EG; Urcelay E
    Inflamm Bowel Dis; 2007 Dec; 13(12):1484-7. PubMed ID: 17828778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
    Bank S; Skytt Andersen P; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Jürgen Hoffmann H; Kragh Thomsen M; Ostergaard Thomsen V; Frydenberg M; Andersen Nexø B; Sode J; Vogel U; Andersen V
    PLoS One; 2014; 9(6):e98815. PubMed ID: 24971461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort.
    Hume GE; Fowler EV; Griffiths LR; Doecke JD; Radford-Smith GL
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):349-55. PubMed ID: 23256116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
    Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
    Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort.
    Poliska S; Penyige A; Lakatos PL; ; Papp M; Palatka K; Lakatos L; Molnar T; Nagy L
    Inflamm Bowel Dis; 2012 Mar; 18(3):472-9. PubMed ID: 21710534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation.
    Mencarelli A; Distrutti E; Renga B; D'Amore C; Cipriani S; Palladino G; Donini A; Ricci P; Fiorucci S
    PLoS One; 2011; 6(7):e22978. PubMed ID: 21829567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis.
    Aoyagi Y; Nagata S; Kudo T; Fujii T; Wada M; Chiba Y; Ohtsuka Y; Yamashiro Y; Shimizu T; Ohkusa T
    Pediatr Int; 2010 Oct; 52(5):729-34. PubMed ID: 20591056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.
    Atug O; Tahan V; Eren F; Tiftikci A; Imeryuz N; Hamzaoglu HO; Tozun N
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):433-7. PubMed ID: 19104705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
    Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis.
    Sun MY; Lin JN
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):230-239. PubMed ID: 27894906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
    Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Hoffmann HJ; Andersen Nexø B; Sode J; Vogel U; Andersen V
    PLoS One; 2015; 10(12):e0145302. PubMed ID: 26698117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 and inflammatory bowel disease: a meta-analysis.
    Zhang ZF; Yang N; Zhao G; Zhu L; Wang LX
    PLoS One; 2012; 7(1):e30551. PubMed ID: 22276212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.
    Andersen V; Nimmo E; Krarup HB; Drummond H; Christensen J; Ho GT; Ostergaard M; Ernst A; Lees C; Jacobsen BA; Satsangi J; Vogel U
    Inflamm Bowel Dis; 2011 Apr; 17(4):937-46. PubMed ID: 20803508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.
    Andersen V; Ernst A; Christensen J; Østergaard M; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
    BMC Med Genet; 2010 May; 11():82. PubMed ID: 20509889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.